Candice Clarke

Candice Clarke

Auto-generated profile, based on publicly available information

Candice Clarke

Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London W12 0HS, United Kingdom; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, United Kingdom

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2020 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
CCCandice Clarke
Candice Clarke
MPMaria Prendecki
Maria Prendecki
ADAmrita Dhutia
Amrita Dhutia
MAMahrukh A. Ali
Mahrukh A. Ali
HSHira Sajjad
Hira Sajjad
MWMichelle Willicombe
Michelle Willicombe
Significance Statement: Strategies to limit acquisition and transmission of SARS-CoV-2 infection in patients with ESKD receiving in-center hemodialysis have been implemented globally. Despite these measures, acute SARS-CoV-2 infection rates confirmed by RT-PCR testing have been high in the United Kingdom. The seroprevalence rate in an in-center hemodialysis adult population has not been reported previously. In a study of 356 patients receiving in-center hemodialysis, the authors report a 36.3% seroprevalence rate. They also found that 40.3% of patients with IgG SARS-CoV-2 antibodies had either asymptomatic infection or undetected disease by PCR testing alone. These findings reveal limitations of current diagnostic screening strategies for active SARS-CoV-2 infection using PCR testing of individuals screened for symptoms prior to dialysis sessions. Effective screening is likely to require a hybrid strategy of PCR and serologic testing. Background: Strategies to minimize the risk of transmission and acquisition of COVID-19 infection in patients with ESKD receiving in-center hemodialysis have been rapidly implemented across the globe. Despite these interventions, confirmed COVID-19 infection rates have been high in the United Kingdom. Prevalence of asymptomatic disease in an adult hemodialysis population has not been reported. Also, to our knowledge, the development of humoral response to SARS-CoV-2 has not been previously reported in this population. Although serologic testing does not provide information on the infectivity of patients, seroprevalence studies may enable investigation of exposure within dialysis units and hence, assessment of current screening strategies. Methods: To investigate the seroprevalence of SARS-CoV-2 antibodies in a hemodialysis population, we used the Abbott IgG assay with the Architect system to test serum samples from 356 patients receiving in-center hemodialysis for SARS-CoV-2 antibodies. Results: Of 356 patients, 121 had been symptomatic when screened before a dialysis session and received an RT-PCR test; 79 (22.2% of the total study population) tested positive for COVID-19. Serologic testing of all 356 patients found 129 (36.2%) who tested positive for SARS-CoV-2 antibodies. Only two patients with PCR-confirmed infection did not seroconvert. Of the 129 patients with SARS-CoV-2 antibodies, 52 (40.3%) had asymptomatic disease or undetected disease by PCR testing alone. Conclusions: We found a high seroprevalence of SARS-CoV-2 antibodies in patients receiving in-center hemodialysis. Serologic evidence of previous infection in asymptomatic or PCR-negative patients suggests that current diagnostic screening strategies may be limited in their ability to detect acute infection.

1 September 2020 in Kidney International
Verified
Journal Article
Closed access
MPMaria Prendecki
Maria Prendecki
CCCandice Clarke
Candice Clarke
TCTom Cairns
Tom Cairns
TCTerry Cook
Terry Cook
CRCandice Roufosse
Candice Roufosse
SMStephen P. McAdoo
Stephen P. McAdoo

19 November 2014 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
MWMichelle Willicombe
Michelle Willicombe
NKNicola Kumar
Nicola Kumar
DGDawn Goodall
Dawn Goodall
CCCandice Clarke
Candice Clarke
AMAdam G. McLean
Adam G. McLean
DTDavid Taube
David Taube

3 April 2014 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
ZMZoë McDonald-Burrows
Zoë McDonald-Burrows
RDRhian Davies
Rhian Davies
EGElizabeth Goode
Elizabeth Goode
CCCandice Clarke
Candice Clarke
JJJames Jackson
James Jackson
PSPhilip Savage
Philip Savage
Gestational trophoblastic tumours are a rare form of malignancy, which in the majority of cases arise from abnormal trophoblast cells formed in a complete molar pregnancy. These tumours are extremely sensitive to chemotherapy and high cure rates approaching 100% can be expected. The disease is usually limited to the uterus where the abnormal trophoblast proliferation and human chorionic production can lead to vascular changes including the formation of arteriovenous malformations.

1 May 2016 in Transplantation
Verified
Journal Article
Closed access
VGVeronika Grau
Veronika Grau
PZPhilip Zeuschner
Philip Zeuschner
SIStephan Immenschuh
Stephan Immenschuh
CBClemens Luitpold Bockmeyer
Clemens Luitpold Bockmeyer
SZStefanie Zell
Stefanie Zell
JBJan Ulrich Becker
Jan Ulrich Becker
Antibody-mediated rejection is a leading cause for renal transplant loss. Rodent models are useful to dissect pathomechanisms and to develop treatment strategies. Although used for decades as a model, glomerular histopathological findings of Fischer-344 kidneys transplanted into Lewis rats have never been comprehensively described. Kidneys from Fischer-344 rats were transplanted into Lewis rats as life-sustaining allografts without immunosuppression. Lewis isografts and normal Fischer-344 kidneys served as controls. Grafts were harvested at 9 days, 6 and 26 weeks. Histopathological examination included light microscopy, immunohistochemistry, and morphometry. Findings were compared with 51 human biopsies with transplant glomerulopathy. Most glomerular findings in rat allografts resembled human acute and chronic antibody-mediated rejection with glomerulitis, microthrombosis, microaneurysms, glomerular hypertrophy, podocyte loss, glomerular basement membrane splitting, and secondary focal and segmental glomerulosclerosis. In line with previous reports on nonendothelial antigens, glomerular immunoglobulin and C4d deposition was mostly nonendothelial. Only in 26-week allografts, we found mesangial and subendothelial immune complex-type electron-dense deposits. Similar deposits were found in 8 of 51 human biopsies with transplant glomerulopathy after rigorous exclusion of immune complexes of other cause, particularly recurrent glomerulonephritis and hepatitis C. Thus, our model closely reflects the glomerular changes of acute antibody-mediated rejection in humans and of a special subset of human transplant glomerulopathy. The significance of alloimmune immune complex-type deposits in human transplants deserves further investigation.

1 May 2017 in Clinical Nephrology
Verified
Journal Article
Closed access
DADamien Ashby
Damien Ashby
MBMark Busbridge
Mark Busbridge
SHSarah Hildebrand
Sarah Hildebrand
CCCandice Clarke
Candice Clarke
GAGeorgina Aldous
Georgina Aldous
PCPeter Choi
Peter Choi
The discovery of hepcidin, the hormone regulating iron absorption and transport, has improved the understanding of anemia and erythropoietin treatment. Excessive hepcidin signaling causes anemia in chronic inflammatory conditions by restricting iron delivery to the bone marrow. Hepcidin is normally eliminated in the urine, and the high levels seen in renal failure are thought to contribute to renal anemia and resistance to erythropoietin.